CCR2 and essential thrombocythemia: We found that the percentage of CCR2+ cells was significantly higher in patients who received a diagnosis of sMF as compared to those who reveled only slight fibrosis progression and therefore, could not be allocated into post-PV/ET disease category (ET/PV-F) (P=0.0012, Figure 2A).